Literature DB >> 7768552

Potassium negatively regulates angiotensin II type 1 receptor expression in human adrenocortical H295R cells.

I M Bird1, R A Word, C Clyne, J I Mason, W E Rainey.   

Abstract

We have previously shown that the human adrenocortical H295R cell line expresses the type 1 angiotensin II receptor (AT1-R) and that expression of this receptor is downregulated at the level of mRNA by forskolin or dibutyryl-cAMP as well as by angiotensin II (Ang II). In this study we examine the effects of K+ on both AT1-R mRNA and receptors, as monitored through 125I-Ang II binding in the presence of PD 123319. After treatment with a maximal stimulatory steroidogenic dose of K+ (14 mmol/L), H295R cells showed an increase in cytosolic free Ca2+ from 113 to 212 nmol/L. Unlike the effects of Ang II, this increase could be abolished by pretreatment with the Ca2+ channel antagonist nifedipine (1 mumol/L). AT1-R mRNA levels also fell in response to elevated extracellular K+ in a dose-dependent (Kd, 9 mmol/L; maximal fall in message at 12 mmol/L) and time-dependent (maximum 50% at 12 hours) manner. The change in AT1-R mRNA level was less rapid than that in response to activation of phosphoinositidase C by Ang II or adenylyl cyclase by forskolin or by dibutyryl-cAMP. Unlike the action of Ang II but similar to the action of forskolin or dibutyryl-cAMP, the action of K+ was sustained. Changes in mRNA level in response to treatment with K+, Ang II, or dibutyryl-cAMP were also paralleled by changes in 125I-Ang II binding in each case.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768552     DOI: 10.1161/01.hyp.25.6.1129

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

Review 1.  Regulation of the Na+/K+-ATPase by insulin: why and how?

Authors:  G Sweeney; A Klip
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

2.  Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways.

Authors:  Hong Weng Pang; Andrea Linares; Leena Couling; Jessica Santollo; Leonardo Ancheta; Derek Daniels; Robert C Speth
Journal:  Endocrine       Date:  2019-04-24       Impact factor: 3.633

Review 3.  Human adrenocortical carcinoma cell lines.

Authors:  Tao Wang; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2011-09-05       Impact factor: 4.102

Review 4.  Angiotensin II regulation of adrenocortical gene transcription.

Authors:  Edson F Nogueira; Wendy B Bollag; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2008-09-03       Impact factor: 4.102

5.  Diminished antiproteinuric effect of the angiotensin receptor blocker losartan during high potassium intake in patients with CKD.

Authors:  Rosa D Wouda; Femke Waanders; Dick de Zeeuw; Gerjan Navis; Liffert Vogt
Journal:  Clin Kidney J       Date:  2021-02-05

6.  Suppression of aldosterone synthesis and secretion by ca(2+) channel antagonists.

Authors:  Keiichi Ikeda; Tsuyoshi Isaka; Kouki Fujioka; Yoshinobu Manome; Katsuyoshi Tojo
Journal:  Int J Endocrinol       Date:  2012-10-11       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.